Asesoramiento genético a mujeres en edad fértil sobrevivientes de cáncer


  • Isabel Castro Volio Universidad de Costa Rica


Palabras clave:

cáncer, embarazo, asesoramiento genético, sobrevivientes


Las personas que han padecido cáncer en su infancia, adolescencia, o antes de la menopausia, y han sobrevivido, merecen, además de cantidad, calidad de vida. Un aspecto muy importante del bienestar personal se relaciona con la procreación. Lamentablemente, es posible que las mismas terapias que les han salvado la vida, puedan comprometer su fertilidad, el pronóstico del embarazo y del parto, o la salud del bebé. De igual manera, en aquellos tipos de cáncer con influencia hormonal, nace la duda sobre la prudencia de un embarazo posterior. Otro aspecto fundamental es la posibilidad de transmitir el cáncer a generaciones futuras. El objetivo de esta revisión es apoyar al personal de salud en el abordaje de esta temática e ilustrar la forma como el asesoramiento genético puede contribuir al manejo de estos casos


Baker DL, Schuette JL, Uhlmann WR, editores. A guide to genetic counseling. New York: Wiley – Liss; 1998.

Harper PS. Practical genetic counseling. 5th ed. Oxford: Butterworth – Heinemann; 1998.

National Cancer Institute. Elements of cancer genetics risk assessment and counseling (PDQ®). Health professional version. Last modified 01/18/2007. Disponible en:

Robinson LL, Green DM, Hudson M, Meadows AT, Mertens AC,

Packer RJ, et al. Long - term outcomes of adult survivors of childhood cancer. Cancer. 2005; 104: 2557-64.

Sklar CA, Mertens AC, Mitby P, Whitton J, Stoval M, Kasper C, et al. Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006; 98: 890-6.

Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stoval M, Yasui Y, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006; 91: 1723-8.

Schover, LR. After the deluge, the emerging landscape of childbearing potential in pediatric cancer survivors. J Natl Cancer Inst. 2006; 98:1434-35

Brougham MF, Wallace WH. Subfertility in children and young people treated for solid and haematological malignancies. Br J Haematol. 2005; 131:143-55.

Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006; 24: 29172931.

Falcone T, Bedaiwy MA. Fertility preservation and pregnancy outcome after malignancy. Curr Opin Obstet Gynecol. 2005; 17:21-6.

Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004; 10:251-66.

Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001; 7:394-403.

Byrne J, Rasmussen SA, Steinhorn SC, Conneally RR, Myers MH, Lynch CF, et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet. 1998; 62:45-52

Meistrich ML, Byrne J. Genetic disease in offspring of long term survivors of childhood and adolescent cancer treated with potentially mutagenic therapies. Am J Hum Genet. 2002; 70:1069-71.

Boyce JD, Tawn E, Winther JF, Donaldson SS, Green DM, Mertens AC, et al. Genetic effects of radiotherapy for childhood cancer. Health Physics. 2003; 85: 65-80.

Tawn EJ, Whitehouse CA, Winther JF, Curwen GB, Rees GS, Stoval M et al. Chromosome analysis in childhood cancer survivors and their offspring – no evidence for radiotherapy – induced persistent genomic instability. Mutat Res. 2005; 583: 198-206.

Rees GS, Trikic MZ, Winther, JF, Tawn EJ, Stoval M, Olsen JH, et al. A pilot study examining germline minisatellite mutations in the offspring of Danish childhood and adolescent cancer survivors treated with radiotherapy. Int J Radiat Biol. 2006; 82: 153-60.

Meirow D, Schiff E. Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data. J Natl Cancer Inst Monogr. 2005; 34:21-5.

Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr. 2005; 64-8.

Signorello LB, Cohen SS, Bosetti C, Stovall M, Kasper CE, Weathers RE, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst. 2006; 98:1453-61.

Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol. 2002; 187:1070-80.

Lantinga GM, Simons AH, Kamps WA, Potsma A. Inminent ovarian failure in childhood cancer survivors. Eur J Cancer. 2006; 42: 1415-20.

Van Dalen EC, van der Pal HJ, van den Bos C, Kok WE, Caron HN, Kremer LC. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. Eur J Cancer. 2006; 42: 2549-53.

Calhoun K, Hansen N. The effect of pregnancy on survival in women with a history of breast cancer. Breast Dis. 2005-2006; 23: 81-6.

Kroman N, Mouridsen HT. Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast. 2003; 12: 516-21.

Park M, Davidson R, Fox K. Preservation of fertility and the impact of subsequent pregnancy in patients with premenopausal breast cancer. Semin Oncol. 2006, 33: 664-71.

Banks E, Reeves G. Pregnancy in women with a history of breast cancer. BMJ. 2007; 334:166-7.

Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ. 2007; 334:194-199.

Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Nat Cancer Inst. 2005; 19:1428-37.

Hill DA, Gilbert E, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E et al. Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood. 2005; 106: 3358-65.

Consejo Nacional de Cáncer. Normas y Procedimientos para el tratamiento de cáncer en Costa Rica. 2005.

Fenlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence. Lyon IARC Press, 2004. Disponible en:

Bennet RL, Hampel HL, Mandell JB, Marks JH. Genetic counselors: translating genomic science into clinical practice. J Clin Invest. 2003;112:1274-79.

Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer. 1997; 71: 800-9.

Friedenson B. Assessing and managing breast cancer risk: clinical tools for advising patients. Med Gen Med. 2004; 6(1):8.

Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Nat Cancer Inst. 2006; 98:1694-1706.

Narod SA. Modifiers of risk of hereditary breast cancer. Oncogene. 2006; 25.5832-6.

Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer. 2005; 117:988-91.

Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, et al. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res. 2006; 8:R15

Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S, Thorlacius S, Jonasson JG, Tulinius H, et al. BRCA2 mutation carriers, reproductive factors and breast cancer risk. Breast Cancer Res. 2003, 5:R121-R128 (DOI 10.1186/bcr619).

Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R, Antoniou AC, et al. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst. 2006; 98:535-44.

Antoniou AC, Shenton A, Maher ER, Watson E, Woodward E, Lallo F, et al. Parity and breast cancer risk among BRCA 1 and BRCA 2 mutation carriers. Breast Cancer Res. 2006; 8:R72.




Cómo citar

Castro Volio, I. (2007). Asesoramiento genético a mujeres en edad fértil sobrevivientes de cáncer. Acta Médica Costarricense, 49(4), 190–197.